Bladder smooth muscle dysfunction in patients with irritable bowel syndrome.

Whorwell, Peter J.; Lupton, E. W.; Erduran, Doğan; Wilson, K. M.

doi:10.1136/gut.27.9.1014

Cited by 126 publications

(70 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Interestingly, the bowel dysfunction is as bothersome to patients with detrusor instability. Idiopathic detrusor instability is associated with irritable bowel syndrome in up to 30% of patients [149], probably caused by a common intrinsic disorder of smooth muscle and nerve supply. This rather than bile salt (or other) malabsorption may explain the bowel problems ensuing after augmentation in this group.…”

Section: Bowel Disturbancementioning

confidence: 99%

Augmentation cystoplasty

Greenwell¹,

Venn²,

Mundy³

2001

BJU International

193

137

View full text Add to dashboard Cite

Section: Bowel Disturbancementioning

confidence: 99%

Augmentation cystoplasty

Greenwell¹,

Venn²,

Mundy³

2001

BJU International

193

137

View full text Add to dashboard Cite

“…14 Patients with IBS may have many extraintestinal, in particular urinary, symptoms and they are frequently referred to urologists, gynaecologists and gastrointestinal surgeons. [15][16][17][18][19][20] There is an excess of hysterectomy, cholecystectomy and laparoscopy 19,21,22 among these patients and it may be that some of these procedures result from the diagnostic confusion engendered by IBS symptoms. In addition to the direct and indirect costs of IBS there is a significant opportunity cost to the NHS in terms of reduction in the availability of investigation and treatment for patients with other disorders such as inflammatory bowel disease, gastrointestinal cancer and gynaecological pathology.…”

Section: (See Boxes 1 and 2)mentioning

confidence: 99%

Cognitive behavioural therapy in addition to antispasmodic therapy for irritable bowel syndrome in primary care: randomised controlled trial

Kennedy¹,

Chalder²,

McCrone³

et al. 2006

Health Technol Assess

View full text Add to dashboard Cite

Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per monograph and for the rest of the world £3 per monograph.You can order HTA monographs from our Despatch Agents:-fax (with credit card or official purchase order) -post (with credit card or official purchase order or cheque) -phone during office hours (credit card only).Additionally the HTA website allows you either to pay securely by credit card or to print out your order and then post or fax it. Contact Payment methods Paying by chequeIf you pay by cheque, the cheque must be in pounds sterling, made payable to Direct Mail Works Ltd and drawn on a bank with a UK address. Paying by credit cardThe following cards are accepted by phone, fax, post or via the website ordering pages: Delta, Eurocard, Mastercard, Solo, Switch and Visa. We advise against sending credit card details in a plain email.Paying by official purchase order You can post or fax these, but they must be from public bodies (i.e. NHS or universities) within the UK.We cannot at present accept purchase orders from commercial companies or from outside the UK. How do I get a copy of HTA on CD?Please use the form on the HTA website (www.hta.ac.uk/htacd.htm). Or contact Direct Mail Works (see contact details above) by email, post, fax or phone. HTA on CD is currently free of charge worldwide.The website also provides information about the HTA Programme and lists the membership of the various committees. HTA NHS R&D HTA ProgrammeT he research findings from the NHS R&D Health Technology Assessment (HTA) Programme directly influence key decision-making bodies such as the National Institute for Health and Clinical Excellence (NICE) and the National Screening Committee (NSC) who rely on HTA outputs to help raise standards of care. HTA findings also help to improve the quality of the service in the NHS indirectly in that they form a key component of the 'National Knowledge Service' that is being developed to improve the evidence of clinical practice throughout the NHS.The HTA Programme was set up in 1993. Its role is to ensure that high-quality research information on the costs, effectiveness and broader impact of health technologies is produced in the most efficient way for those who use, manage and provide care in the NHS. 'Health technologies' are broadly defined to include all interventions used to promote health, prevent and treat disease, and improve rehabilitation and long-term care, rather than settings of care.The HTA Programme commissions research only on topics where it has identified key gaps in the evidence needed by the NHS. Suggestions for topics are actively sought from people working in the NHS, the public, service-users groups and professional bodies such as Royal Colleges and NHS Trusts.Research suggestions are carefully considered by panels of independent experts (including service users) whose advice results in a ranked list of recommended research priorities. The HTA Programme then commissions the research team best suited to und...

show abstract

“…7,8 Symptoms unrelated to the digestive system are prevalent in IBS patients. [9][10][11][12][13] These symptoms may be significant and entail invasive diagnostic and therapeutic procedures, as shown by a significant increase in the rate of back surgery in IBS patients reported in a large-scale study. 14 As bowel symptoms suggestive of IBS are prevalent in NERD patients, 15 we sought to determine whether these patients exhibit multisystemic nondigestive features as well.…”

Section: Introductionmentioning

confidence: 99%

“…The presence of NDS is characteristic of IBS patients. [9][10][11][12][13] Some of these symptoms, such as urinary frequency, may be explained on the basis of visceral hypersensitivity, whereas in others, notably musculoskeletal pain, such a relationship is less straightforward. In a previous study, the degree of NDSs in IBS patients, assessed by the same scales used in this study, was comparable to or even higher than that reported by IBD patients.…”

mentioning

confidence: 99%